Semin Liver Dis 2012; 32(02): 167-176
DOI: 10.1055/s-0032-1316472
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Liver Toxicity of Antiretroviral Drugs

Michelle Jones
1   Section on Infectious Diseases, Department of Internal Medicine, Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC
,
Marina Núñez
1   Section on Infectious Diseases, Department of Internal Medicine, Wake Forest University Health Sciences, Medical Center Boulevard, Winston Salem, NC
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
03. Juli 2012 (online)

Zoom Image

Abstract

Drug-induced liver injury (DILI) associated with antiretroviral treatment has represented an important side effect since the beginning of the HAART era. The lack of standard definition and specific markers makes assessment of DILI very challenging. Several clinical syndromes of DILI have been described over the years; the pathogenic mechanisms are not fully understood. Better knowledge of DILI, identification of high-risk patients using pharmacogenetics, and the availability of antiretroviral agents with improved safety profile have all contributed to decrease the incidence of DILI and to ameliorate its effects. Nevertheless, with an aging human immunodeficiency virus- (HIV-) infected population and increased survival, DILI will probably continue to represent a relevant entity in e HIV therapeutic management.